Literature DB >> 16829398

The effect of continuous enteral tube feeding on various nutritional parameters in patients with disseminated malignant melanoma during intensive chemotherapy.

J M Smit1, N H Mulder, D T Sleijfer, J G Bouman, W Veeger, H Schraffordt Koops.   

Abstract

In a prospective study the effect of continuous enteral tube feeding was evaluated on various nutritional parameters in patients with disseminated malignant melanoma during 13 chemotherapy courses employing bleomycin, DTIC, vindesine and actinomycin D. The patients received a quantity of calories according to their pretreatment intake, but complete metabolic equilibrium could not be obtained during chemotherapy. Although the weight/height index remained unchanged, a decrease of serum albumin and prealbumin level occurred during all 13 treatment courses. Transferrin level decreased during 11 of these courses and cholinesterase level during 12. Triceps skinfold thickness and arm muscle circumference diminished equally. Serum prealbumin was the first nutritional parameter to fall during chemotherapy and seems to be a very sensitive indicator of the occurrence of nutritional imbalance. The plasma vitamin C level was low before treatment while during treatment both vitamin C and vitamin A level fell quickly even though the nutritional intake of these vitamins was adequate. We conclude that continuous enteral tube feeding, which is a feasible method of feeding, can to some extent fulfill the nutritional needs of patients treated with intensive chemotherapy.

Entities:  

Year:  1983        PMID: 16829398     DOI: 10.1016/0261-5614(83)90012-2

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  3 in total

1.  Tube feeding of cancer patients treated with chemotherapy.

Authors:  E G de Vries; W M Kreumer; D L Schippers; N H Mulder
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

2.  Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy--a longitudinal study.

Authors:  M N Harvie; A Howell; N Thatcher; A Baildam; I Campbell
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

3.  Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review.

Authors:  Markus S Anker; Richard Holcomb; Maurizio Muscaritoli; Stephan von Haehling; Wilhelm Haverkamp; Aminah Jatoi; John E Morley; Florian Strasser; Ulf Landmesser; Andrew J S Coats; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-02       Impact factor: 12.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.